Latest AGRX reports update at 2024-05-15: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Agile Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Agile Therapeutics logo
Agile Therapeutics AGRX
$ 0.6 10.11%
mail-toReport an Error

Agile Therapeutics EV/EBITDA Ratio 2011-2024 | AGRX

Annual EV/EBITDA Ratio Agile Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-18.5 -5.1 -8.16 -1.14 -2.83 -1.05 -3.49 -3.99 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.05 -18.5 -5.53